Quarterly report pursuant to Section 13 or 15(d)

Acquisitions, Investments and Licenses - Variable Interest Entities Narrative (Details)

v3.5.0.2
Acquisitions, Investments and Licenses - Variable Interest Entities Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 9 Months Ended
Jul. 09, 2015
Jun. 30, 2016
Nov. 30, 2015
Jun. 30, 2012
Sep. 30, 2016
Sep. 30, 2015
Jun. 30, 2015
Variable Interest Entity [Line Items]              
Gain on deconsolidation of SciVac         $ 0 $ 17,340  
Merger transaction gain         $ 2,500    
Zebra              
Variable Interest Entity [Line Items]              
Ownership percentage         29.00%    
Stock ownership percentage         29.00%    
Additional investment     $ 1,000        
VBI Vaccines Inc              
Variable Interest Entity [Line Items]              
Ownership percentage         17.00%    
Additional investment   $ 5,700          
Additional shares purchased   1,362,370          
Series A-2 Preferred Stock | Zebra              
Variable Interest Entity [Line Items]              
Investment owned, shares         1,260,000    
Additional shares purchased     420,000        
Restricted Stock | Zebra              
Variable Interest Entity [Line Items]              
Shares received as a gift         900,000    
SciVac              
Variable Interest Entity [Line Items]              
Gain on deconsolidation of SciVac           $ 17,300  
SciVac | Variable Interest Entity, Primary Beneficiary              
Variable Interest Entity [Line Items]              
Stock ownership percentage       50.00%      
Additional working capital             $ 7,900
VBI Vaccines Inc.              
Variable Interest Entity [Line Items]              
Stock ownership percentage 24.50%            
Cash contribution $ 21,200